|
市場調査レポート
商品コード
1072067
抗炎症薬の世界市場:展望・予測 (2022-2027年)Anti-Inflammatory Drugs Market - Global Outlook & Forecast 2022-2027 |
||||||
抗炎症薬の世界市場:展望・予測 (2022-2027年) |
出版日: 2022年04月28日
発行: Arizton Advisory & Intelligence
ページ情報: 英文 326 Pages
納期: 即納可能
|
世界の抗炎症薬の市場規模は予測期間中6.78%のCAGRで成長すると予測されています。
大規模な患者グループによるOTC抗炎症薬の購買行動の増加、各種炎症性疾患の有病率の上昇、炎症性疾患の治療における生物製剤の使用の増加などの要因が同市場の成長を推進しています。
当レポートでは、世界の抗炎症薬の市場を調査し、市場概要、市場成長への各種影響因子の分析、主要動向、市場規模の推移・予測、各種区分・地域別の詳細分析、競合環境、主要企業のプロファイルなどをまとめています。
LIST OF TABLES
LATIN AMERICA ANTI-INFLAMMATORY DRUGS MARKET BY ROUTE OF ADMINISTRATION 2021-2027 ($ BILLION)
The study considers a detailed scenario of the present global anti-inflammatory drugs market and its market dynamics for 2022-2027. It covers a detailed overview of several market growth enablers, restraints, and trends. The report offers both the demand and supply aspects of the market. It profiles and examines leading companies and other prominent ones operating in the market.
The global anti-inflammatory drugs market is expected to grow at a CAGR of 6.78% during 2022-2027
MARKET GROWTH AND OPPORTUNITIES
GLOBAL ANTI-INFLAMMATORY DRUGS MARKET SHARE AND SEGMENTS
Segmentation by Drug Class
Segmentation by Application
Segmentation by Route of Administration
GEOGRAPHICAL ANALYSIS
In 2021, North America was the major revenue contributor and accounted for 41.38% in the global anti-inflammatory drugs market in 2021 and witness the highest incremental growth of $20.88 billion during the forecast period.
Increasing population, the emergence of autoimmune diseases, expansion of demand, increase in pharma and biopharma facilities, and the advent of COVID-19 are major factors to boost the demand for anti-inflammatory drugs in Europe.
Segmentation by Geography
VENDOR ANALYSIS
Key Vendors
Other Prominent Vendors